First Time Loading...

BioPlus Acquisition Corp
NASDAQ:BIOS

Watchlist Manager
BioPlus Acquisition Corp Logo
BioPlus Acquisition Corp
NASDAQ:BIOS
Watchlist
Price: 10.795 USD Market Closed
Updated: Apr 25, 2024

Intrinsic Value

BIOS's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

BioPlus Acquisition Corp. operates as a blank check company. [ Read More ]

The intrinsic value of one BIOS stock under the Base Case scenario is 12.025 USD. Compared to the current market price of 10.795 USD, BioPlus Acquisition Corp is Undervalued by 10%.

Key Points:
BIOS Intrinsic Value
Base Case
12.025 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
BioPlus Acquisition Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BIOS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
BioPlus Acquisition Corp

Provide an overview of the primary business activities
of BioPlus Acquisition Corp.

What unique competitive advantages
does BioPlus Acquisition Corp hold over its rivals?

What risks and challenges
does BioPlus Acquisition Corp face in the near future?

Summarize the latest earnings call
of BioPlus Acquisition Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioPlus Acquisition Corp.

Provide P/S
for BioPlus Acquisition Corp.

Provide P/E
for BioPlus Acquisition Corp.

Provide P/OCF
for BioPlus Acquisition Corp.

Provide P/FCFE
for BioPlus Acquisition Corp.

Provide P/B
for BioPlus Acquisition Corp.

Provide EV/S
for BioPlus Acquisition Corp.

Provide EV/GP
for BioPlus Acquisition Corp.

Provide EV/EBITDA
for BioPlus Acquisition Corp.

Provide EV/EBIT
for BioPlus Acquisition Corp.

Provide EV/OCF
for BioPlus Acquisition Corp.

Provide EV/FCFF
for BioPlus Acquisition Corp.

Provide EV/IC
for BioPlus Acquisition Corp.

Show me price targets
for BioPlus Acquisition Corp made by professional analysts.

What are the Revenue projections
for BioPlus Acquisition Corp?

How accurate were the past Revenue estimates
for BioPlus Acquisition Corp?

What are the Net Income projections
for BioPlus Acquisition Corp?

How accurate were the past Net Income estimates
for BioPlus Acquisition Corp?

What are the EPS projections
for BioPlus Acquisition Corp?

How accurate were the past EPS estimates
for BioPlus Acquisition Corp?

What are the EBIT projections
for BioPlus Acquisition Corp?

How accurate were the past EBIT estimates
for BioPlus Acquisition Corp?

Compare the revenue forecasts
for BioPlus Acquisition Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioPlus Acquisition Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioPlus Acquisition Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioPlus Acquisition Corp compared to its peers.

Compare the P/E ratios
of BioPlus Acquisition Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing BioPlus Acquisition Corp with its peers.

Analyze the financial leverage
of BioPlus Acquisition Corp compared to its main competitors.

Show all profitability ratios
for BioPlus Acquisition Corp.

Provide ROE
for BioPlus Acquisition Corp.

Provide ROA
for BioPlus Acquisition Corp.

Provide ROIC
for BioPlus Acquisition Corp.

Provide ROCE
for BioPlus Acquisition Corp.

Provide Gross Margin
for BioPlus Acquisition Corp.

Provide Operating Margin
for BioPlus Acquisition Corp.

Provide Net Margin
for BioPlus Acquisition Corp.

Provide FCF Margin
for BioPlus Acquisition Corp.

Show all solvency ratios
for BioPlus Acquisition Corp.

Provide D/E Ratio
for BioPlus Acquisition Corp.

Provide D/A Ratio
for BioPlus Acquisition Corp.

Provide Interest Coverage Ratio
for BioPlus Acquisition Corp.

Provide Altman Z-Score Ratio
for BioPlus Acquisition Corp.

Provide Quick Ratio
for BioPlus Acquisition Corp.

Provide Current Ratio
for BioPlus Acquisition Corp.

Provide Cash Ratio
for BioPlus Acquisition Corp.

What is the historical Revenue growth
over the last 5 years for BioPlus Acquisition Corp?

What is the historical Net Income growth
over the last 5 years for BioPlus Acquisition Corp?

What is the current Free Cash Flow
of BioPlus Acquisition Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioPlus Acquisition Corp.

Financials

Balance Sheet Decomposition
BioPlus Acquisition Corp

Current Assets 196.8k
Cash & Short-Term Investments 2.5k
Other Current Assets 194.4k
Non-Current Assets 138.4m
Long-Term Investments 138.4m
Current Liabilities 2m
Accrued Liabilities 408.8k
Short-Term Debt 250k
Other Current Liabilities 1.3m
Non-Current Liabilities 14.8m
Long-Term Debt 5m
Other Non-Current Liabilities 9.8m
Efficiency

Earnings Waterfall
BioPlus Acquisition Corp

Revenue
0 USD
Operating Expenses
-2.2m USD
Operating Income
-2.2m USD
Other Expenses
8m USD
Net Income
5.8m USD

Free Cash Flow Analysis
BioPlus Acquisition Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BIOS Profitability Score
Profitability Due Diligence

BioPlus Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Low ROE
Negative ROIC
Negative Operating Income
41/100
Profitability
Score

BioPlus Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

BIOS Solvency Score
Solvency Due Diligence

BioPlus Acquisition Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
59/100
Solvency
Score

BioPlus Acquisition Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOS Price Targets Summary
BioPlus Acquisition Corp

Wall Street analysts forecast BIOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOS is 20 USD .

Lowest
Price Target
Not Available
Average
Price Target
20 USD
85% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BIOS Price
BioPlus Acquisition Corp

1M 1M
-
6M 6M
-
1Y 1Y
+3%
3Y 3Y
+10%
5Y 5Y
+10%
10Y 10Y
+10%
Annual Price Range
10.795
52w Low
10.46
52w High
10.84
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -1%
Shares Statistics
Market Capitalization 209.1m USD
Shares Outstanding 19 367 500
Percentage of Shares Shorted 0.01%

BIOS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

BioPlus Acquisition Corp Logo
BioPlus Acquisition Corp

Country

United States of America

Industry

N/A

Market Cap

209.1m USD

Dividend Yield

0%

Description

BioPlus Acquisition Corp. operates as a blank check company. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2021-12-03. The firm is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on companies in the life sciences industry. The firm has not commenced any operations nor generated any revenue.

Contact

NEW YORK
New York City
260 Madison Avenue, Suite 800
+12122874092.0

IPO

2021-12-03

Employees

2

Officers

Chairman & Chief Bus. Officer
Mr. Jonathan M. N. Rigby MBA
CEO, CFO & Director
Mr. Ross Haghighat

See Also

Discover More
What is the Intrinsic Value of one BIOS stock?

The intrinsic value of one BIOS stock under the Base Case scenario is 12.025 USD.

Is BIOS stock undervalued or overvalued?

Compared to the current market price of 10.795 USD, BioPlus Acquisition Corp is Undervalued by 10%.